Posts

Montelukast/Singulair now has a "black box" warning by the FDA due to neuropsychiatric events

No effect from montelukast on respiratory symptoms and lung function in wheezy infants

Montelukast failure index shows risk of failure before treatment is started

Identification of asthmatic patients who respond to Singulair (montelukast) is important as response is variable

Montelukast works better than salmeterol for exercise-induced asthma in children (study sponsored by Merck)

Intravenous montelukast not helpful in children with acute asthma